India to Armenia: Carfilzomib Export Trade Route
India has recorded 17 verified shipments of Carfilzomib exported to Armenia, representing a combined trade value of $43.1K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $2.5K USD. The leading Indian exporter is RGSK CANADA HEALTHCARE INC., which accounts for 60% of total export value with 7 shipments worth $25.7K USD. On the buying side, VLADIMIR GASPARYAN is the largest importer in Armenia with $23.2K USD in purchases. The top 3 suppliers — RGSK CANADA HEALTHCARE INC., RGSK CANADA HEALTHCARE INC, TOWADA PRODUCTS — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Armenia Carfilzomib corridor is one of India's established pharmaceutical export routes, with 17 shipments documented worth a combined $43.1K USD. The route is dominated by RGSK CANADA HEALTHCARE INC., which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's carfilzomib manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $2.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with carfilzomib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 13.7%, placing it at rank #20 among India's top carfilzomib export destinations globally.
On the import side, key buyers of Indian carfilzomib in Armenia include VLADIMIR GASPARYAN, VLADIMIR GASPARYAN APP, LALA HAKOBYAN and 6 others. VLADIMIR GASPARYAN is the single largest importer with 6 shipments valued at $23.2K USD.
Route Characteristics
- Average transit31 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#20
- Annual growth+13.7%
- Demand growth+13.9%
- Regulatory ease85/100
Top 10 Indian Carfilzomib Exporters to Armenia
Showing top 10 of 5 Indian suppliers exporting Carfilzomib to Armenia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RGSK CANADA HEALTHCARE INC. Avg $3.7K per shipment | 7 | $25.7K | 59.8% |
| 2 | RGSK CANADA HEALTHCARE INC Avg $5.8K per shipment | 2 | $11.6K | 27.0% |
| 3 | TOWADA PRODUCTS Avg $711 per shipment | 6 | $4.3K | 9.9% |
| 4 | TOWADA PRODUCTS Avg $1.2K per shipment | 1 | $1.2K | 2.8% |
| 5 | P KUMAR AGENCY Avg $234 per shipment | 1 | $234 | 0.5% |
This table shows the top 10 of 5 Indian companies exporting carfilzomib to Armenia, ranked by total trade value. The listed exporters are: RGSK CANADA HEALTHCARE INC., RGSK CANADA HEALTHCARE INC, TOWADA PRODUCTS , TOWADA PRODUCTS, P KUMAR AGENCY. RGSK CANADA HEALTHCARE INC. is the dominant supplier with 7 shipments worth $25.7K USD, giving it a 60% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Top 10 Carfilzomib Importers in Armenia
Showing top 10 of 9 known buyers in Armenia receiving Carfilzomib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian carfilzomib in Armenia include VLADIMIR GASPARYAN, VLADIMIR GASPARYAN APP, LALA HAKOBYAN, LIANNA KONJORYAN , ASHKHEN GEVORGYAN , among 9 total buyers. The largest importer is VLADIMIR GASPARYAN, accounting for $23.2K USD across 6 shipments — representing 54% of all carfilzomib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VLADIMIR GASPARYAN | 6 | $23.2K | 53.8% |
| 2 | VLADIMIR GASPARYAN APP | 2 | $11.6K | 27.0% |
| 3 | LALA HAKOBYAN | 1 | $2.6K | 6.0% |
| 4 | LIANNA KONJORYAN | 2 | $1.4K | 3.2% |
| 5 | ASHKHEN GEVORGYAN | 2 | $1.2K | 2.9% |
| 6 | GULANYAN GAGIK | 1 | $1.2K | 2.8% |
| 7 | ARMEN MINASYAN | 1 | $976 | 2.3% |
| 8 | SONA HARUTYUNYAN | 1 | $646 | 1.5% |
| 9 | EDGAR KHACHATRYAN | 1 | $234 | 0.5% |
Top 10 Carfilzomib Formulations Imported by Armenia
Showing top 10 of 12 product formulations shipped on the India to Armenia Carfilzomib route, ranked by trade value
Armenia imports a wide range of carfilzomib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CARFILZOMIB FOR INJECTION 60MG BATCH NO — accounts for $8.4K USD across 2 shipments. There are 12 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CARFILZOMIB FOR INJECTION 60MG BATCH NO | 2 | $8.4K | 19.6% |
| 2 | CARFILZOMIB FOR INJECTION 60MG B NO JD40 | 2 | $8.3K | 19.3% |
| 3 | CARFILZOMIB FOR INJECTION 60 MG B.NO.JD40823004 MANUFACTURING -06/23 EXP-11/24 B.NO. JD40823005 MANUFACTURING -07/2023 EXP-12/2024 | 1 | $5.8K | 13.5% |
| 4 | CARFILZOMIB FOR INJECTION 60 MG B.NO.JD40823004 MANUFACTURING -06/23 EXP-11/24 B.NO. JD40823004 MANUFACTURING -07/2023 EXP-12/2024 | 1 | $5.8K | 13.5% |
| 5 | CARFILZOMIB FOR INJECTION 60MG BN JD40824001JD40823010MF DT 01/24 EXP DT 06/25MF DT 11/23 EXP DT 04/25 | 1 | $3.2K | 7.4% |
| 6 | CARFILZOMIB FOR INJECTION 60MG B NO-JD40823008 MFG 10/2023 XP 03/2025 ,B.NO JD40823010,MFG 11/2023,EXP 04/2025 | 1 | $3.2K | 7.4% |
| 7 | CARFILZOMIB FOR INJECTION 60MG(CARFILNATINJ.60MG)BN.JD40824005,MD.05/2024,ED.10/2025,BN.JD40824008,MD.10/24,ED.03/2026 | 1 | $2.6K | 6.0% |
| 8 | CARFILNAT 60 MG (CARFILZOMIB 60 MG) (1 | 3 | $1.9K | 4.4% |
| 9 | CARFILNAT 60 MG (CARFILZOMIB (60 MG)) (1 | 2 | $1.4K | 3.2% |
| 10 | CARFILNAT 60 MG CARFILZOMIB 60 MG 1PCS BATCH NO JD40822002 MFG DATE 02 2022 EXP DATE 01 2024 | 1 | $1.2K | 2.8% |
Showing top 10 of 12 Carfilzomib formulations imported by Armenia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 6 shipments. Transit time averages 31 days by sea.
Market Dynamics
India's carfilzomib exports to Armenia are driven primarily by a handful of large-scale manufacturers. RGSK CANADA HEALTHCARE INC. with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Armenia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — RGSK CANADA HEALTHCARE INC., RGSK CANADA HEALTHCARE INC, TOWADA PRODUCTS — together account for 97% of total trade value on this route. The average shipment value of $2.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as carfilzomib for injection 60mg b no jd40 and carfilzomib for injection 60 mg b.no.jd40823004 manufacturing -06/23 exp-11/24 b.no. jd40823005 manufacturing -07/2023 exp-12/2024, suggesting that buyers in Armenia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, VLADIMIR GASPARYAN is the largest importer with 6 shipments worth $23.2K USD — representing 54% of all carfilzomib imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $43.1K
- Avg. Shipment
- $2.5K
- Suppliers
- 5
- Buyers
- 9
- Transit (Sea)
- ~31 days
- Annual Growth
- +13.7%
Related Analysis
Other Carfilzomib Routes
Unlock the Full India to Armenia Carfilzomib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 17 shipments on this route.
Frequently Asked Questions — India to Armenia Carfilzomib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Carfilzomib to Armenia?
The leading Indian exporters of Carfilzomib to Armenia are RGSK CANADA HEALTHCARE INC., RGSK CANADA HEALTHCARE INC, TOWADA PRODUCTS . RGSK CANADA HEALTHCARE INC. holds the largest market share at approximately 60% of total trade value on this route.
Q What is the total value of Carfilzomib exports from India to Armenia?
India exports Carfilzomib to Armenia worth approximately $43.1K USD across 17 recorded shipments. The average value per shipment is $2.5K USD.
Q Which ports does India use to ship Carfilzomib to Armenia?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 6 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to Armenia for Carfilzomib?
The average transit time for Carfilzomib shipments from India to Armenia is approximately 31 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Armenia Carfilzomib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 13.7% with demand growth tracking at 13.9%. The route is ranked #20 among India's top Carfilzomib export destinations globally.
Q How many suppliers are active on the India to Armenia Carfilzomib route?
There are currently 5 active Indian suppliers exporting Carfilzomib to Armenia. The market is moderately concentrated with RGSK CANADA HEALTHCARE INC. accounting for 60% of total shipment value.
Q Who are the main importers of Carfilzomib from India in Armenia?
The leading importers of Indian Carfilzomib in Armenia include VLADIMIR GASPARYAN, VLADIMIR GASPARYAN APP, LALA HAKOBYAN, LIANNA KONJORYAN , ASHKHEN GEVORGYAN . VLADIMIR GASPARYAN is the largest buyer with 6 shipments worth $23.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Armenia export trade corridor identified from Indian Customs (DGFT) records for Carfilzomib.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 9 importers in Armenia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 17 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
17 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists